New biotechnology companies seek out
well known and well established biotechnology and pharmaceutical companies with
which to collaborate. Being associated with these trusted players helps address
the legitimacy and credibility issues that automatically attach themselves to
most new ventures. It can also help them gain additional influence within their
sector and attract increased funding from investors.
The Italian oil company Eni has a long
standing reputation for seeking to forge alliances with African national oil
companies. The fact that they did this first, at a time when other
international oil companies showed little or no interest, and have consistently
maintained and developed this approach over many decades, has made them a
partner of choice for many national oil companies.
The IT company Intel has gained much collaborative capital from its high profile and highly
successful history of collaborations with others from within its sector.
Being involved in fruitful
collaborations with key competitors and others of present or potential
significance provides companies with collaborative capital that is as valuable
as money in the bank. Organisations can use this capital to enhance their
legitimacy and credibility, gain influence within their sector or industry and
become a trusted partner of choice for their competitors.
For more about collaboration go to: Sleeping-with-the-Enemy-Achieving-Collaborative-Success-2nd-Edition
No comments:
Post a Comment